These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 27698452)

  • 1. Kupffer cells induce Notch-mediated hepatocyte conversion in a common mouse model of intrahepatic cholangiocarcinoma.
    Terada M; Horisawa K; Miura S; Takashima Y; Ohkawa Y; Sekiya S; Matsuda-Ito K; Suzuki A
    Sci Rep; 2016 Oct; 6():34691. PubMed ID: 27698452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes.
    Sekiya S; Suzuki A
    J Clin Invest; 2012 Nov; 122(11):3914-8. PubMed ID: 23023701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice.
    Wang J; Dong M; Xu Z; Song X; Zhang S; Qiao Y; Che L; Gordan J; Hu K; Liu Y; Calvisi DF; Chen X
    Oncogene; 2018 Jun; 37(24):3229-3242. PubMed ID: 29545603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholangiocarcinomas can originate from hepatocytes in mice.
    Fan B; Malato Y; Calvisi DF; Naqvi S; Razumilava N; Ribback S; Gores GJ; Dombrowski F; Evert M; Chen X; Willenbring H
    J Clin Invest; 2012 Aug; 122(8):2911-5. PubMed ID: 22797301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch1 is overexpressed in human intrahepatic cholangiocarcinoma and is associated with its proliferation, invasiveness and sensitivity to 5-fluorouracil in vitro.
    Wu WR; Zhang R; Shi XD; Zhu MS; Xu LB; Zeng H; Liu C
    Oncol Rep; 2014 Jun; 31(6):2515-24. PubMed ID: 24700253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell lineage tracing reveals a biliary origin of intrahepatic cholangiocarcinoma.
    Guest RV; Boulter L; Kendall TJ; Minnis-Lyons SE; Walker R; Wigmore SJ; Sansom OJ; Forbes SJ
    Cancer Res; 2014 Feb; 74(4):1005-10. PubMed ID: 24310400
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Matsumori T; Kodama Y; Takai A; Shiokawa M; Nishikawa Y; Matsumoto T; Takeda H; Marui S; Okada H; Hirano T; Kuwada T; Sogabe Y; Kakiuchi N; Tomono T; Mima A; Morita T; Ueda T; Tsuda M; Yamauchi Y; Kuriyama K; Sakuma Y; Ota Y; Maruno T; Uza N; Marusawa H; Kageyama R; Chiba T; Seno H
    Cancer Res; 2020 Dec; 80(23):5305-5316. PubMed ID: 33067264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma.
    Mu X; Pradere JP; Affò S; Dapito DH; Friedman R; Lefkovitch JH; Schwabe RF
    Gastroenterology; 2016 Mar; 150(3):720-33. PubMed ID: 26627606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Notch signaling is required for cholangiocarcinoma progression and is enhanced by inactivation of p53 in vivo.
    El Khatib M; Bozko P; Palagani V; Malek NP; Wilkens L; Plentz RR
    PLoS One; 2013; 8(10):e77433. PubMed ID: 24204826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch1 Drives the Formation and Proliferation of Intrahepatic Cholangiocarcinoma.
    Guo J; Fu W; Xiang M; Zhang Y; Zhou K; Xu CR; Li L; Kuang D; Ye F
    Curr Med Sci; 2019 Dec; 39(6):929-937. PubMed ID: 31845224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of FoxA2 accelerates neoplastic changes in the intrahepatic bile duct partly via the MAPK signaling pathway.
    Shen J; Zhou Y; Zhang X; Peng W; Peng C; Zhou Q; Li C; Wen T; Shi Y
    Aging (Albany NY); 2019 Nov; 11(21):9280-9294. PubMed ID: 31689237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NOTCH-YAP1/TEAD-DNMT1 Axis Drives Hepatocyte Reprogramming Into Intrahepatic Cholangiocarcinoma.
    Hu S; Molina L; Tao J; Liu S; Hassan M; Singh S; Poddar M; Bell A; Sia D; Oertel M; Raeman R; Nejak-Bowen K; Singhi A; Luo J; Monga SP; Ko S
    Gastroenterology; 2022 Aug; 163(2):449-465. PubMed ID: 35550144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic potential of IDH1R132C mutant in cholangiocarcinoma development in mice.
    Ding N; Che L; Li XL; Liu Y; Jiang LJ; Fan B; Tao JY; Chen X; Ji JF
    World J Gastroenterol; 2016 Feb; 22(6):2071-80. PubMed ID: 26877611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma cell proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling.
    Tang J; Liao Y; He S; Shi J; Peng L; Xu X; Xie F; Diao N; Huang J; Xie Q; Lin C; Luo X; Liao K; Ma J; Li J; Zhou D; Li Z; Xu J; Zhong C; Wang G; Bai L
    J Transl Med; 2017 Nov; 15(1):238. PubMed ID: 29178939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF receptor-related factor 3 inactivation promotes the development of intrahepatic cholangiocarcinoma through NF-κB-inducing kinase-mediated hepatocyte transdifferentiation.
    Shiode Y; Kodama T; Shigeno S; Murai K; Tanaka S; Newberg JY; Kondo J; Kobayashi S; Yamada R; Hikita H; Sakamori R; Suemizu H; Tatsumi T; Eguchi H; Jenkins NA; Copeland NG; Takehara T
    Hepatology; 2023 Feb; 77(2):395-410. PubMed ID: 34995376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the role of STAT3 in intrahepatic cholangiocarcinoma (Review).
    Yang R; Song Y; Shakoor K; Yi W; Peng C; Liu S
    Mol Med Rep; 2022 May; 25(5):. PubMed ID: 35302174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological significance of aberrant Notch receptors in intrahepatic cholangiocarcinoma.
    Wu WR; Shi XD; Zhang R; Zhu MS; Xu LB; Yu XH; Zeng H; Wang J; Liu C
    Int J Clin Exp Pathol; 2014; 7(6):3272-9. PubMed ID: 25031748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MFAP5 facilitates the aggressiveness of intrahepatic Cholangiocarcinoma by activating the Notch1 signaling pathway.
    Li JH; Zhu XX; Li FX; Huang CS; Huang XT; Wang JQ; Gao ZX; Li SJ; Xu QC; Zhao W; Yin XY
    J Exp Clin Cancer Res; 2019 Nov; 38(1):476. PubMed ID: 31775892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anatomic and molecular pathology of intrahepatic cholangiocarcinoma.
    Nakanuma Y; Harada K; Ishikawa A; Zen Y; Sasaki M
    J Hepatobiliary Pancreat Surg; 2003; 10(4):265-81. PubMed ID: 14598145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic cholangiocarcinoma arising in chronic advanced liver disease and the cholangiocarcinomatous component of hepatocellular cholangiocarcinoma share common phenotypes and cholangiocarcinogenesis.
    Xu J; Sasaki M; Harada K; Sato Y; Ikeda H; Kim JH; Yu E; Nakanuma Y
    Histopathology; 2011 Dec; 59(6):1090-9. PubMed ID: 22175889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.